"New Jersey Urology is the leader in complete urologic care. As an all-inclusive practice, NJU is dedicated to providing comprehensive individualized treatment for all patients."

During the past decade, New Jersey Urology - Saddle Brook conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Jersey Urology - Saddle Brook" #1 collaborator was "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator and "Helsinn Healthcare SA" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "New Jersey Urology - Saddle Brook" are "Prostate Cancer" (2 trials), "Upper Tract Urothelial Carcinomas" (1 trials) and "Urothelial Bladder Cancer" (1 trials). Many other conditions were trialed in "New Jersey Urology - Saddle Brook" in a lesser frequency.

Most popular intervention types in "New Jersey Urology - Saddle Brook" are "Drug" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aglatimagene besadenovec + valacyclovir" (1 trials), "Darolutamide" (1 trials), "External Beam Radiotherapy" (1 trials), "Infigratinib" (1 trials) and "Luteinizing Hormone-Releasing Hormone Analog" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Jersey Urology - Saddle Brook" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "New Jersey Urology - Saddle Brook". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in New Jersey Urology - Saddle Brook, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Jersey Urology - Saddle Brook, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".